Jackson Square Capital, LLC Amgen Inc Transaction History

Jackson Square Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Mar 05, 2021	SELL	$216.38 - $257.67 $56,475 - $67,251	-261 Closed	0 $0
Q2 2020 Aug 18, 2020	SELL	$197.81 - $242.74 $6,132 - $7,524	-31 Reduced 10.62%	261 $62,000
Q1 2020 May 15, 2020	BUY	$182.24 - $241.7 $2,551 - $3,383	14 Added 5.04%	292 $59,000
Q4 2019 May 15, 2020	BUY	$189.21 - $243.2 $52,600 - $67,609	278 New	278 $67,000

3,057

409M

7.19M

6.3M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $171B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Jackson Square Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Jackson Square Capital, LLC with notifications on news.